These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12136675)

  • 1. [Therapy of hypertension. A new rapidly effective AT1 blocker].
    MMW Fortschr Med; 2002 Jun; 144(25):55. PubMed ID: 12136675
    [No Abstract]   [Full Text] [Related]  

  • 2. A new class of antihypertensive: angiotensin II receptor antagonists.
    McCoy R
    S D J Med; 1995 Sep; 48(9):319-20. PubMed ID: 7481726
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of hypertension. AT1 blockers soon to be the first choice?].
    MMW Fortschr Med; 2002 May; 144(19):64. PubMed ID: 12116560
    [No Abstract]   [Full Text] [Related]  

  • 4. [New AT1-blocker is approved; "me too" or progress?].
    MMW Fortschr Med; 2002 Oct; 144(40):51. PubMed ID: 12440302
    [No Abstract]   [Full Text] [Related]  

  • 5. [Angiotensin II receptor antagonists. Clinical relevance].
    Scholze J
    Internist (Berl); 1996 Jun; 37(6):636-42. PubMed ID: 8767999
    [No Abstract]   [Full Text] [Related]  

  • 6. [Not just blood pressure counts. How well are hypertensive patients controlled?].
    MMW Fortschr Med; 2003 Sep; 145(38):64. PubMed ID: 14603692
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypertension. Guidelines recommend fixed combinations].
    MMW Fortschr Med; 2014 Apr; 156(7):62-3. PubMed ID: 24956662
    [No Abstract]   [Full Text] [Related]  

  • 8. Tribenzor for hypertension.
    Med Lett Drugs Ther; 2010 Sep; 52(1346):70-1. PubMed ID: 20814402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [AT1 blocker therapy of hypertension in seniors. Added protection for cerebral blood vessels?].
    MMW Fortschr Med; 2003 Jan; 145(1-2):53. PubMed ID: 12638442
    [No Abstract]   [Full Text] [Related]  

  • 11. [From the beginning -- a strong-acting and well tolerable antihypertensive agent. The recipe against constant change].
    MMW Fortschr Med; 2003 Dec; 145(49):57. PubMed ID: 14963998
    [No Abstract]   [Full Text] [Related]  

  • 12. [Organ protection in hypertensive type 2 diabetic patients. Double chance with AT1 blockers].
    MMW Fortschr Med; 2000 Jan; 142(3):58-9. PubMed ID: 10726465
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversible ageusia associated with losartan.
    Schlienger RG; Saxer M; Haefeli WE
    Lancet; 1996 Feb; 347(8999):471-2. PubMed ID: 8618505
    [No Abstract]   [Full Text] [Related]  

  • 14. Two amlodipine/ARB combinations for hypertension.
    Med Lett Drugs Ther; 2007 Dec; 49(1276):101-2. PubMed ID: 18084152
    [No Abstract]   [Full Text] [Related]  

  • 15. Antihypertensive efficacy of olmesartan compared with other antihypertensive drugs.
    Stumpe KO; Ludwig M
    J Hum Hypertens; 2002 May; 16 Suppl 2():S24-8. PubMed ID: 11967729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Losartan for hypertension.
    Med Lett Drugs Ther; 1995 Jun; 37(951):57-8. PubMed ID: 7783693
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and efficacy of olmesartan: an observational pooled-analysis of 156,682 hypertensive patients.
    Scholze J; Schaefer A; Kreutz R
    Expert Opin Drug Saf; 2011 Mar; 10(2):185-96. PubMed ID: 21254872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fast and strong lowering of pressure. The newest sartan has passed the practice test].
    MMW Fortschr Med; 2003 Oct; 145(44):45. PubMed ID: 14655509
    [No Abstract]   [Full Text] [Related]  

  • 19. Losartan--a new antihypertensive.
    Drug Ther Bull; 1995 Oct; 33(10):73-4. PubMed ID: 7493558
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-hypertensive therapy by losartan. How effective is AT1 receptor blockade?
    Brunner HR
    J Hum Hypertens; 1995 Nov; 9(11):859-60. PubMed ID: 8583462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.